Prediagnostic plasma vitamin B6 (pyridoxal 5 '-phosphate) and survival in patients with colorectal cancer
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Je, Youjin | - |
dc.contributor.author | Lee, Jung Eun | - |
dc.contributor.author | Ma, Jing | - |
dc.contributor.author | Zhang, Xuehong | - |
dc.contributor.author | Cho, Eunyoung | - |
dc.contributor.author | Rosner, Bernard | - |
dc.contributor.author | Selhub, Jacob | - |
dc.contributor.author | Fuchs, Charles S. | - |
dc.contributor.author | Meyerhardt, Jeffrey | - |
dc.contributor.author | Giovannucci, Edward | - |
dc.date.available | 2021-02-22T12:16:27Z | - |
dc.date.issued | 2013-04 | - |
dc.identifier.issn | 0957-5243 | - |
dc.identifier.issn | 1573-7225 | - |
dc.identifier.uri | https://scholarworks.sookmyung.ac.kr/handle/2020.sw.sookmyung/11307 | - |
dc.description.abstract | Higher plasma pyridoxal 5'-phosphate (PLP) levels are associated with a decreased incidence of colorectal cancer, but the influence of plasma PLP on survival of patients with colorectal cancer is unknown. We prospectively examined whether prediagnostic plasma PLP levels are associated with mortality among colorectal cancer patients. We included 472 incident cases of colorectal cancer identified in the Nurses' Health Study, the Health Professionals Follow-up Study, and the Physicians' Health Study from 1984 to 2002. The patients provided blood samples two or more years before cancer diagnosis. Stratified Cox proportional hazards models were used to calculate hazard ratios (HR) with 95 % confidence intervals (CI) adjusted for other risk factors for cancer survival. Higher plasma PLP levels were not associated with a significant reduction in colorectal cancer-specific (169 deaths) or overall mortality (259 deaths). Compared with patients who had less than 45 pmol/ml of plasma PLP (median: 33.6 pmol/ml), those who had 110 pmol/ml or higher levels (median: 158.8 pmol/ml) had multivariable HRs of 0.85 (95 % CI 0.50-1.45, p trend = 0.37) and 0.87 (95 % CI 0.56-1.35, p trend = 0.24) for colorectal cancer-specific and overall mortality. Higher plasma PLP levels, however, seemed to be associated with better survival among patients who had lower circulating 25-hydroxyvitamin D-3 levels (< 26.5 ng/ml) (p interaction a parts per thousand currency sign.005). Higher prediagnostic plasma PLP levels were not associated with an improvement on colorectal cancer survival overall. Further research is needed to clarify the influence of vitamin B6 on colorectal cancer progression and survival. | - |
dc.format.extent | 11 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | SPRINGER | - |
dc.title | Prediagnostic plasma vitamin B6 (pyridoxal 5 '-phosphate) and survival in patients with colorectal cancer | - |
dc.type | Article | - |
dc.publisher.location | 네델란드 | - |
dc.identifier.doi | 10.1007/s10552-013-0152-x | - |
dc.identifier.scopusid | 2-s2.0-84876483783 | - |
dc.identifier.wosid | 000316352900010 | - |
dc.identifier.bibliographicCitation | CANCER CAUSES & CONTROL, v.24, no.4, pp 719 - 729 | - |
dc.citation.title | CANCER CAUSES & CONTROL | - |
dc.citation.volume | 24 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 719 | - |
dc.citation.endPage | 729 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | sci | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalResearchArea | Public, Environmental & Occupational Health | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.relation.journalWebOfScienceCategory | Public, Environmental & Occupational Health | - |
dc.subject.keywordPlus | NATIONAL DEATH INDEX | - |
dc.subject.keywordPlus | THYMIDYLATE SYNTHASE | - |
dc.subject.keywordPlus | COLON TUMORIGENESIS | - |
dc.subject.keywordPlus | CELL-PROLIFERATION | - |
dc.subject.keywordPlus | REGRESSION-MODELS | - |
dc.subject.keywordPlus | NURSES HEALTH | - |
dc.subject.keywordPlus | RISK | - |
dc.subject.keywordPlus | FOLATE | - |
dc.subject.keywordPlus | INHIBITION | - |
dc.subject.keywordPlus | ASSAY | - |
dc.subject.keywordAuthor | Vitamin B6 | - |
dc.subject.keywordAuthor | Pyridoxal 5 ' phosphate (PLP) | - |
dc.subject.keywordAuthor | Colorectal cancer | - |
dc.subject.keywordAuthor | Mortality | - |
dc.subject.keywordAuthor | Survival | - |
dc.subject.keywordAuthor | Prospective study | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Sookmyung Women's University. Cheongpa-ro 47-gil 100 (Cheongpa-dong 2ga), Yongsan-gu, Seoul, 04310, Korea02-710-9127
Copyright©Sookmyung Women's University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.